Tanja Skyttä

1.6k total citations
46 papers, 649 citations indexed

About

Tanja Skyttä is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tanja Skyttä has authored 46 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 23 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tanja Skyttä's work include Chemotherapy-induced cardiotoxicity and mitigation (22 papers), Cardiac Imaging and Diagnostics (13 papers) and Cardiovascular Function and Risk Factors (9 papers). Tanja Skyttä is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (22 papers), Cardiac Imaging and Diagnostics (13 papers) and Cardiovascular Function and Risk Factors (9 papers). Tanja Skyttä collaborates with scholars based in Finland, United Kingdom and Netherlands. Tanja Skyttä's co-authors include Pirkko‐Liisa Kellokumpu‐Lehtinen, Suvi Tuohinen, Pekka Raatikainen, Vesa Virtanen, Eeva Boman, Mika Kapanen, M Rossi, Tiina Luukkaala, Simo Hyödynmaa and Heini Huhtala and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Heart Journal.

In The Last Decade

Tanja Skyttä

44 papers receiving 647 citations

Peers

Countries citing papers authored by Tanja Skyttä

Since Specialization

Citations

This map shows the geographic impact of Tanja Skyttä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Skyttä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Skyttä more than expected).

Fields of papers citing papers by Tanja Skyttä

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Skyttä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Skyttä. The network helps show where Tanja Skyttä may publish in the future.

Co-authorship network of co-authors of Tanja Skyttä

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Skyttä. A scholar is included among the top collaborators of Tanja Skyttä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Skyttä. Tanja Skyttä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term risk for incident cancer in patients undergoing coronary artery bypass grafting with or without cardiopulmonary bypass: a nationwide population-based study 2025 ·European Journal of Cardio-Thoracic Surgery ·Ari Mennander, Susanne J. Nielsen, Tanja Skyttä, (unknown), Andreas Martinsson, Aldina Pivodic, Emma C. Hansson, Anders Jeppsson	1
2	Cardiac surgery and long-term risk for incident cancer: A nationwide population-based study 2024 ·Journal of Thoracic and Cardiovascular Surgery ·Ari Mennander, Susanne J. Nielsen, Tanja Skyttä, (unknown), Andreas Martinsson, Aldina Pivodic, Emma C. Hansson, Anders Jeppsson	1
3	Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients – multimodality imaging study with six-year follow-up 2023 ·Radiation Oncology ·(unknown), Tanja Skyttä, Sari Kivistö, Heini Huhtala, Kjell Nikus, Vesa Virtanen, Pirkko‐Liisa Kellokumpu‐Lehtinen, Pekka Raatikainen, Suvi Tuohinen	7
4	Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor 2022 ·Acta Oncologica ·Kalle Mattila, Siru Mäkelä, Soili Kytölä, Emma Andersson, Pia Vihinen, (unknown), Tanja Skyttä, Leena Tiainen, Meri‐Sisko Vuoristo, (unknown), Jussi Koivunen, (unknown), Kristiina Aittomäki, Micaela Hernberg	4
5	Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial 2021 ·Clinical Cancer Research ·Reetta Virtakoivu, Jenna H. Rannikko, Miro Viitala, Felix Vaura, Akira Takeda, Tapio Lönnberg, Jussi Koivunen, Panu Jaakkola, Annika Pasanen, Shishir Shetty, Maja J.A. de Jonge, Debbie Robbrecht, Yuk Ting, Tanja Skyttä, Anna Minchom, Sirpa Jalkanen, Matti K. Karvonen, Jami Mandelin, Petri Bono, Maija Hollmén	41
6	Changes in diastology and atrial function in multimodality imaging after breast cancer radiotherapy - a six-year follow-up study 2021 ·European Heart Journal - Cardiovascular Imaging ·(unknown), (unknown), Sari Kivistö, Tanja Skyttä, (unknown), (unknown), Pekka Raatikainen, Vesa Virtanen, Kjell Nikus, Suvi Tuohinen	1
7	1024MO A phase I/II MATINS trial: Part 1 pharmacokinetic, safety and efficacy results of Clever-1 blockade in advanced cancer 2020 ·Annals of Oncology ·Petri Bono, Panu Jaakkola, Shishir Shetty, Yuk Ting, Maja J.A. de Jonge, Debbie Robbrecht, Anna Minchom, Abhijit Pal, Christina Yap, Annika Pasanen, Tanja Skyttä, Alain Thibault, (unknown), Markku Jalkanen, Sirpa Jalkanen, Maija Hollmén, Jami Mandelin, Matti K. Karvonen, Jussi Koivunen	1
8	Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy 2020 ·Clinical Breast Cancer ·(unknown), (unknown), Tanja Skyttä, Pirkko‐Liisa Kellokumpu‐Lehtinen, Maarit Bärlund	15
9	Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer 2020 ·Current Heart Failure Reports ·Agneta Månsson‐Broberg, Jürgen Geisler, Suvi Tuohinen, Tanja Skyttä, Þórdís Jóna Hrafnkelsdóttir, Kirsten Melgaard Nielsen, Elham Hedayati, Torbjørn Omland, Birgitte Vrou Offersen, Alexander R. Lyon, Geeta Gulati	13
10	Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer 2019 ·Radiation Oncology ·(unknown), Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen, Pirkko‐Liisa Kellokumpu‐Lehtinen	8
11	ST2 levels increased and were associated with changes in left ventricular systolic function during a three-year follow-up after adjuvant radiotherapy for breast cancer 2019 ·The Breast ·(unknown), Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen, Pirkko‐Liisa Kellokumpu‐Lehtinen	13
12	Left Ventricular Speckle Tracking Echocardiography Changes Among Early-stage Breast Cancer Patients Three Years After Radiotherapy 2019 ·Anticancer Research ·Suvi Tuohinen, Tanja Skyttä, Heini Huhtala, Vesa Virtanen, Pirkko‐Liisa Kellokumpu‐Lehtinen, Pekka Raatikainen	18
13	Adjuvant radiotherapy-induced cardiac changes among patients with early breast cancer: a three-year follow-up study 2019 ·Acta Oncologica ·Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Vesa Virtanen, Pekka Raatikainen, Pirkko‐Liisa Kellokumpu‐Lehtinen	22
14	Decreases in TGF-β1 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer 2018 ·Radiation Oncology ·(unknown), Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen, Pirkko‐Liisa Kellokumpu‐Lehtinen	10
15	Adjuvant Breast Cancer Treatments Induce Changes in Homoarginine Level – A Prospective Observational Study 2017 ·Anticancer Research ·(unknown), Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen, Pirkko‐Liisa Kellokumpu‐Lehtinen	2
16	Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: speckle tracking echocardiography study 2016 ·International journal of cardiac imaging ·Suvi Tuohinen, Tanja Skyttä, Tuija Poutanen, Heini Huhtala, Vesa Virtanen, Pirkko‐Liisa Kellokumpu‐Lehtinen, Pekka Raatikainen	42
17	A new split arc VMAT technique for lymph node positive breast cancer 2016 ·Physica Medica ·Eeva Boman, M Rossi, (unknown), Tanja Skyttä, Mika Kapanen	37
18	Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy 2015 ·Radiation Oncology ·Tanja Skyttä, Suvi Tuohinen, Eeva Boman, Vesa Virtanen, Pekka Raatikainen, Pirkko‐Liisa Kellokumpu‐Lehtinen	107
19	Determination of the optimal matching position for setup images and minimal setup margins in adjuvant radiotherapy of breast and lymph nodes treated in voluntary deep inhalation breath-hold 2015 ·Radiation Oncology ·(unknown), Mika Kapanen, (unknown), Tanja Skyttä, (unknown), Simo Hyödynmaa, Pirkko‐Liisa Kellokumpu‐Lehtinen	18
20	Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab 2011 ·Melanoma Research ·Pia Vihinen, (unknown), Meri‐Sisko Vuoristo, Micaela Hernberg, (unknown), Tanja Skyttä, Ilkka Koskivuo, Pirkko‐Liisa Kellokumpu‐Lehtinen, Karí Syrjänen, Seppo Pyrhönen	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact